CAS 796967-16-3 appears in our catalog under these names: Linifanib, >95% (HPLC), Linifanib/ 99.29% (existing batch purity), Linifanib (ABT–869), Linifanib, >95.0%(HPLC)(qNMR), Linifanib. Offered by: TRC, TargetMol, GLPBio, TCI, Chemat. Available pack sizes: 1mg, 25mg, 5mg, 10mg, 50mg, 100mg, 200mg, 500mg.
Linifanib is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 2-fluoro-5-methylphenyl group, while the other is substituted by a p-(3-amino-1H-indazol-4-yl)phenyl group. It is a potent, selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinases. It has a role as an antineoplastic agent, an angiogenesis inhibitor and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a member of phenylureas, an aromatic amine and a member of indazoles.
Source: ChEBI
| Molecular formula | C21H18FN5O |
|---|---|
| Molecular weight | 375.4 g/mol |
| IUPAC name | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea |
| InChIKey | MPVGZUGXCQEXTM-UHFFFAOYSA-N |
| SMILES | CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N |
Computed by PubChem (NCBI)